Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Int J Cancer. 2015 Jan 7;137(3):744–749. doi: 10.1002/ijc.29414

Figure 2.

Figure 2

In contrast to sunitinib, dopamine (DA) treatment had no significant toxic effect on liver and renal functions compared to untreated controls as was determined by (a) alanine aminotransferase (ALT) (b) aspartate aminotransferase (AST) (c) total bilirubin (TBILI) (d) blood urea nitrogen (BUN) and (e) Creatinine (Creat) levels in serum of untreated and treated (DA and sunitinib) normal, HT29 and LLC tumor bearing mice. Results are mean ± SE of three separate experiments; n=13 per group;*P < 0.05 when compared to respective controls.